Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $6,876 | 8 | 36.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,620 | 3 | 29.9% |
| Honoraria | $3,072 | 1 | 16.4% |
| Consulting Fee | $2,188 | 1 | 11.6% |
| Food and Beverage | $1,021 | 14 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Advanced Accelerator Applications | $9,028 | 6 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $5,503 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $2,230 | 3 | $0 (2024) |
| Curium US LLC | $1,737 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $153.75 | 2 | $0 (2024) |
| GE HEALTHCARE | $126.43 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,096 | 12 | Novartis Pharmaceuticals Corporation ($2,211) |
| 2023 | $150.79 | 2 | AstraZeneca Pharmaceuticals LP ($131.37) |
| 2022 | $45.42 | 2 | Siemens Medical Solutions USA, Inc. ($45.42) |
| 2020 | $5,337 | 3 | Siemens Medical Solutions USA, Inc. ($5,337) |
| 2019 | $6,076 | 7 | Advanced Accelerator Applications ($5,956) |
| 2018 | $3,072 | 1 | Advanced Accelerator Applications ($3,072) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Oncology | ||||||
| 12/02/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $102.57 | General |
| 11/07/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 10/10/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| 05/05/2024 | Curium US LLC | — | Travel and Lodging | Cash or cash equivalent | $385.03 | General |
| 05/05/2024 | Curium US LLC | — | Travel and Lodging | Cash or cash equivalent | $245.79 | General |
| 05/05/2024 | Curium US LLC | — | Food and Beverage | Cash or cash equivalent | $145.97 | General |
| 05/04/2024 | Curium US LLC | — | Travel and Lodging | Cash or cash equivalent | $331.20 | General |
| 05/04/2024 | Curium US LLC | — | Travel and Lodging | Cash or cash equivalent | $274.85 | General |
| 05/04/2024 | Curium US LLC | — | Travel and Lodging | Cash or cash equivalent | $210.00 | General |
| 05/04/2024 | Curium US LLC | — | Food and Beverage | Cash or cash equivalent | $143.71 | General |
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.38 | General |
| 11/18/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $131.37 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Oncology | ||||||
| 07/06/2022 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $23.23 | General |
| 06/22/2022 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $22.19 | General |
| 06/05/2020 | Siemens Medical Solutions USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 01/03/2020 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $4,828.05 | General |
| 01/03/2020 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $9.00 | General |
| 08/27/2019 | Advanced Accelerator Applications | LUTATHERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,560.00 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 07/24/2019 | Advanced Accelerator Applications | LUTATHERA (Drug) | Travel and Lodging | In-kind items and services | $592.56 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 07/24/2019 | Advanced Accelerator Applications | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $121.45 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 05/23/2019 | Advanced Accelerator Applications | LUTATHERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,560.00 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 05/09/2019 | Advanced Accelerator Applications | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 05/07/2019 | Siemens Medical Solutions USA, Inc. | Biograph mMR (Device), MAGNETOM Vida 3T | Food and Beverage | In-kind items and services | $47.11 | General |
| Category: MR - MRI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,607 | 12,233 | $5.7M | $842,156 |
| 2022 | 20 | 1,248 | 14,516 | $5.1M | $666,876 |
| 2021 | 21 | 1,935 | 20,441 | $7.4M | $930,229 |
| 2020 | 18 | 1,704 | 15,057 | $6.4M | $764,444 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 215 | 236 | $2.3M | $328,907 | 14.2% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 296 | 317 | $503,567 | $133,682 | 26.5% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Office | 2023 | 70 | 94 | $517,784 | $95,844 | 18.5% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 54 | 55 | $574,837 | $81,962 | 14.3% |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | Office | 2023 | 17 | 795 | $143,085 | $43,544 | 30.4% |
| Q9983 | Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | Office | 2023 | 12 | 12 | $47,600 | $35,123 | 73.8% |
| 78814 | Nuclear medicine study limited area with ct scan | Office | 2023 | 20 | 20 | $155,780 | $30,113 | 19.3% |
| 78812 | Nuclear medicine study from skull base to mid-thigh | Office | 2023 | 15 | 20 | $124,260 | $22,405 | 18.0% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 54 | 61 | $377,542 | $15,151 | 4.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 215 | 215 | $301,000 | $9,770 | 3.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 78 | 79 | $59,977 | $8,109 | 13.5% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 42 | 66 | $158,507 | $7,650 | 4.8% |
| 70543 | Mri scan of bone of eye socket, face, and/or neck before and after contrast | Office | 2023 | 23 | 25 | $134,146 | $7,289 | 5.4% |
| 77089 | Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | Office | 2023 | 193 | 193 | $135,100 | $7,093 | 5.3% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2023 | 33 | 38 | $85,328 | $5,290 | 6.2% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 47 | 50 | $10,330 | $1,753 | 17.0% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 79 | 5,877 | $17,239 | $1,517 | 8.8% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Facility | 2023 | 21 | 21 | $6,621 | $1,306 | 19.7% |
| 70553 | Mri scan of brain before and after contrast | Facility | 2023 | 13 | 13 | $7,384 | $1,283 | 17.4% |
| 78816 | Nuclear medicine study whole body with ct scan | Facility | 2023 | 11 | 11 | $16,696 | $1,130 | 6.8% |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | Facility | 2023 | 18 | 18 | $9,000 | $1,088 | 12.1% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 11 | 22 | $10,772 | $661.02 | 6.1% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 14 | 14 | $2,997 | $623.34 | 20.8% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 12 | 12 | $2,473 | $433.93 | 17.5% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 44 | 3,969 | $5,248 | $427.62 | 8.1% |
About Dr. Elcin Zan, MD
Dr. Elcin Zan, MD is a Neuroradiology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1639441215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elcin Zan, MD has received a total of $18,777 in payments from pharmaceutical and medical device companies, with $4,096 received in 2024. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($6,876).
As a Medicare-enrolled provider, Zan has provided services to 6,494 Medicare beneficiaries, totaling 62,247 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Neuroradiology
- Other Specialties Neuroradiology, Nuclear Imaging & Therapy
- Location New York, NY
- Active Since 01/30/2012
- Last Updated 04/03/2023
- Taxonomy Code 2085N0700X
- Entity Type Individual
- NPI Number 1639441215
Products in Payments
- LUTATHERA (Drug) $5,956
- LUTATHERA (lutetium Lu 177 dotatate) (Drug) $3,072
- LYNPARZA (Drug) $131.37
- Biograph mMR (Device) $120.28
- PLUVICTO (Drug) $42.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neuroradiology Doctors in New York
Eytan Raz, Md, MD
Neuroradiology — Payments: $357,208
Dr. Maksim Shapiro, Md, MD
Neuroradiology — Payments: $244,431
Christopher Kellner, M.d, M.D
Neuroradiology — Payments: $172,473
Rafael Ortiz, M.d, M.D
Neuroradiology — Payments: $81,803
Athos Patsalides, Md, MD
Neuroradiology — Payments: $78,328
Dr. Gloria Chiang, M.d, M.D
Neuroradiology — Payments: $11,662